Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Disease Models & Mechanisms|October 30, 2012
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastomaDamini Chand, Yasuo Yamazaki, Kristina Ruuth, et al.
Cancer Research|December 29, 2020
Subcellular Distribution of p53 by the p53-Responsive lncRNA <i>NBAT1</i> Determines Chemotherapeutic Response in NeuroblastomaSanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, et al.
Nucleic Acids Research|January 5, 2024
METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastomaRoshan Vaid, Ketan Thombare, Akram Mendez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2025
HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastomaJuan Yuan, Subhamita Maitra, Eirini Antoniou, et al.
Frontiers in Pediatrics|April 1, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of <sup>177</sup>Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-NFredrik Sundquist, Kleopatra Georgantzi, Kirsten Brunsvig Jarvis, et al.
Nature Communications|January 5, 2020
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Ramy Elgendy, Neda Hekmati, et al.
Nucleic Acids Research|February 8, 2021
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitorsYao Shi, Juan Yuan, Vilma Rraklli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN studyRuth Ladenstein, Dominique Valteau-Couanet, Penelope Brock, et al.
Cancer Research|January 14, 2025
Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell StateBethel Tesfai Embaie, Hirak Sarkar, Adele M Alchahin, et al.
JCI Insight|August 9, 2022
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastomaThale Kristin Olsen, Cecilia Dyberg, Bethel Tesfai Embaie, et al.
Pageof 17